++
About 50% of patients acquiring HIV infection develop an acute infective illness similar to glandular fever within wks of acquiring the single-stranded RNA retrovirus (the HIV seroconversion illness).
++
DxT: fever + lymphadenopathy + severe malaise ± sore throat + a generalised rash → acute HIV
++
If these patients have a negative infectious mononucleosis test, perform an HIV antigen–antibody test or HIV rapid test, which may have to be repeated in 4 wks or so if negative.
++
If positive, confirm diagnosis with western blot test.
++
Patients invariably recover to enter a long period of good health for 5 yrs or more.
++
The level of immune depletion is best measured by the CD4 +ve T-lymphocyte (helper T-cell) count—the CD4 cell count. The cut-off points for good health and severe deficiency disease appear to be 500 cells/μL and 200 cells/μL respectively. The level determines when to initiate combined antiretroviral therapy (cART).
++
Progress of the disease can be measured with the viral load test.
++
Clinical stages of HIV disease
++
++
Typical common clinical presentation of HIV/AIDS
++
Fever of unknown origin
Weight loss (usually severe)
Respiratory: non-productive cough, increasing dyspnoea and fever: due to opportunistic pneumonias (pneumocystis pneumonia may have abrupt or insidious onset)
Gastrointestinal including oral cavity:
Neurological disorders (e.g. headache, dementia, ataxia, seizures, visual loss)
Skin—Kaposi sarcoma and shingles, esp. multidermatomal, infections (viral, bacterial or fungal)
++
Definition of AIDS HIV +ve plus one or more of clinical diseases that are a feature of AIDS, e.g. PJP, KS or CD4 <200.
++
Management Patients with HIV infection require considerable psychosocial support, counselling and regular assessment from a non-judgmental, caring practitioner.
++
The holistic approach to life is recommended ( 493)
++
Support groups and continuing counselling.
++
Medication: current thinking favours treatment, as early as possible (even with CD4+ cell counts >500µL), which should be directed by a HIV specialist, usually at <350 µL.
++
Currently the use of three antiretroviral drugs for ART is preferred: usu. 2 from the NRTI class with one from either the NNRTI or the protease inhibitor group. The HAART (highly active antiretroviral therapy) strategy is a combination of 3 (or more) agents with one or more penetrating the blood–brain barrier. ART treatment does control HIV and allow a near normal lifespan but only two cases of cure have been confirmed as of early 2019.
++
++